{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T10:09:59Z","timestamp":1774778999328,"version":"3.50.1"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2016,6,13]],"date-time":"2016-06-13T00:00:00Z","timestamp":1465776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL068878"],"award-info":[{"award-number":["HL068878"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL105114"],"award-info":[{"award-number":["HL105114"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL088391"],"award-info":[{"award-number":["HL088391"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0157372","type":"journal-article","created":{"date-parts":[[2016,6,13]],"date-time":"2016-06-13T20:40:30Z","timestamp":1465850430000},"page":"e0157372","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["Cardiomyocyte Overexpression of FABP4 Aggravates Pressure Overload-Induced Heart Hypertrophy"],"prefix":"10.1371","volume":"11","author":[{"given":"Ji","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Congzhen","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanbo","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Villacorta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y. Eugene","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jifeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,6,13]]},"reference":[{"issue":"13","key":"ref1","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1161\/01.CIR.0000120390.68287.BB","article-title":"Hypertrophy of the heart: a new therapeutic target?","volume":"109","author":"N Frey","year":"2004","journal-title":"Circulation"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0188-4409(03)00004-3","article-title":"Heart metabolic disturbances in cardiovascular diseases","volume":"34","author":"K Carvajal","year":"2003","journal-title":"Archives of medical research"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.cardiores.2003.11.014","article-title":"Metabolic remodelling of the failing heart: the cardiac burn-out syndrome?","volume":"61","author":"M van Bilsen","year":"2004","journal-title":"Cardiovascular research"},{"issue":"1\u20132","key":"ref4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1440-1681.2006.04342.x","article-title":"Cardiac hypertrophy, substrate utilization and metabolic remodelling: cause or effect?","volume":"33","author":"RH Ritchie","year":"2006","journal-title":"Clinical and experimental pharmacology & physiology"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"e004176","DOI":"10.1161\/JAHA.112.004176","article-title":"Elevated circulating adipocyte-fatty acid binding protein levels predict incident cardiovascular events in a community-based cohort: a 12-year prospective study","volume":"2","author":"WS Chow","year":"2013","journal-title":"Journal of the American Heart Association"},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s11906-004-0036-2","article-title":"Energy substrate metabolism in cardiac hypertrophy","volume":"6","author":"MF Allard","year":"2004","journal-title":"Current hypertension reports"},{"issue":"Suppl 1","key":"ref7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1023\/A:1007792820944","article-title":"Hazards, risks, and threats of heart disease from the early stages to symptomatic coronary heart disease and cardiac failure","volume":"11","author":"WB Kannel","year":"1997","journal-title":"Cardiovascular drugs and therapy \/ sponsored by the International Society of Cardiovascular Pharmacotherapy"},{"issue":"9 Pt 2","key":"ref8","doi-asserted-by":"crossref","first-page":"18S","DOI":"10.1016\/S0895-7061(03)00966-X","article-title":"From hypertension to heart failure: update on the management of systolic and diastolic dysfunction","volume":"16","author":"JB Kostis","year":"2003","journal-title":"American journal of hypertension"},{"issue":"10","key":"ref9","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1172\/JCI30335","article-title":"Cardiomyocyte expression of PPARgamma leads to cardiac dysfunction in mice","volume":"117","author":"NH Son","year":"2007","journal-title":"The Journal of clinical investigation"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1161\/01.RES.0000179226.34112.6d","article-title":"Cardiomyocyte-specific knockout and agonist of peroxisome proliferator-activated receptor-gamma both induce cardiac hypertrophy in mice","volume":"97","author":"SZ Duan","year":"2005","journal-title":"Circulation research"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd2589","article-title":"Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets","volume":"7","author":"M Furuhashi","year":"2008","journal-title":"Nature reviews Drug discovery"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/MCO.0000000000000031","article-title":"Fatty acid binding proteins: tissue-specific functions in health and disease","volume":"17","author":"AE Thumser","year":"2014","journal-title":"Current opinion in clinical nutrition and metabolic care"},{"issue":"7","key":"ref13","first-page":"2640","article-title":"Adipocyte\/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice","volume":"118","author":"M Furuhashi","year":"2008","journal-title":"The Journal of clinical investigation"},{"issue":"5","key":"ref14","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.cmet.2013.04.012","article-title":"Adipocyte lipid chaperone AP2 is a secreted adipokine regulating hepatic glucose production","volume":"17","author":"H Cao","year":"2013","journal-title":"Cell metabolism"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00125-012-2737-4","article-title":"Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease?","volume":"56","author":"S Kralisch","year":"2013","journal-title":"Diabetologia"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.cell.2008.07.048","article-title":"Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism","volume":"134","author":"H Cao","year":"2008","journal-title":"Cell"},{"issue":"7147","key":"ref17","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/nature05844","article-title":"Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2","volume":"447","author":"M Furuhashi","year":"2007","journal-title":"Nature"},{"issue":"11","key":"ref18","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1096\/fj.09-134882","article-title":"Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells","volume":"23","author":"H Elmasri","year":"2009","journal-title":"FASEB journal: official publication of the Federation of American Societies for Experimental Biology"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1007\/s10753-014-9876-3","article-title":"Differential Association of S100A9, an Inflammatory Marker, and p53, a Cell Cycle Marker, Expression with Epicardial Adipocyte Size in Patients with Cardiovascular Disease","volume":"37","author":"RM Agra","year":"2014","journal-title":"Inflammation"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1038\/nutd.2014.3","article-title":"Adipocyte fatty acid-binding protein levels are associated with left ventricular diastolic dysfunction in morbidly obese subjects","volume":"4","author":"A Baessler","year":"2014","journal-title":"Nutrition & diabetes"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.atherosclerosis.2012.07.014","article-title":"Changes in lipid transport-involved proteins of epicardial adipose tissue associated with coronary artery disease","volume":"224","author":"A Salgado-Somoza","year":"2012","journal-title":"Atherosclerosis"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1161\/CIRCRESAHA.109.200501","article-title":"Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease","volume":"105","author":"V Lamounier-Zepter","year":"2009","journal-title":"Circulation research"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1042\/CS20120004","article-title":"Circulating adipocyte fatty acid-binding protein levels are independently associated with heart failure","volume":"124","author":"M Liu","year":"2013","journal-title":"Clinical science"},{"issue":"6","key":"ref24","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1172\/JCI117609","article-title":"Regulated expression of foreign genes in vivo after germline transfer","volume":"94","author":"RS Passman","year":"1994","journal-title":"The Journal of clinical investigation"},{"issue":"25","key":"ref25","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1161\/CIRCULATIONAHA.107.707257","article-title":"Rad GTPase deficiency leads to cardiac hypertrophy","volume":"116","author":"L Chang","year":"2007","journal-title":"Circulation"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/cvr\/cvr068","article-title":"Rad GTPase inhibits cardiac fibrosis through connective tissue growth factor","volume":"91","author":"J Zhang","year":"2011","journal-title":"Cardiovascular research"},{"issue":"16","key":"ref27","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1161\/CIRCULATIONAHA.108.815803","article-title":"Vascular smooth muscle cell-selective peroxisome proliferator-activated receptor-gamma deletion leads to hypotension","volume":"119","author":"L Chang","year":"2009","journal-title":"Circulation"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"H1667","DOI":"10.1152\/ajpheart.01144.2007","article-title":"Blebbistatin extends culture life of adult mouse cardiac myocytes and allows efficient and stable transgene expression","volume":"294","author":"Z Kabaeva","year":"2008","journal-title":"American journal of physiology Heart and circulatory physiology"},{"issue":"10","key":"ref29","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1101\/gad.8.10.1224","article-title":"mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer","volume":"8","author":"P Tontonoz","year":"1994","journal-title":"Genes & development"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1006\/bbrc.1999.1071","article-title":"PPARgamma activation induces the expression of the adipocyte fatty acid binding protein gene in human monocytes","volume":"261","author":"PD Pelton","year":"1999","journal-title":"Biochemical and biophysical research communications"},{"issue":"12","key":"ref31","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.2527\/jas.2009-2124","article-title":"Comparative analysis of fatty acid-binding protein 4 promoters: conservation of peroxisome proliferator-activated receptor binding sites","volume":"87","author":"J Shin","year":"2009","journal-title":"Journal of animal science"},{"issue":"21","key":"ref32","doi-asserted-by":"crossref","first-page":"6640","DOI":"10.1021\/bi0159581","article-title":"Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662","volume":"41","author":"LM Leesnitzer","year":"2002","journal-title":"Biochemistry"},{"issue":"1\u20132","key":"ref33","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11010-007-9442-5","article-title":"Adipocyte fatty acid-binding protein (aP2), a newly identified LXR target gene, is induced by LXR agonists in human THP-1 cells","volume":"302","author":"QY Liu","year":"2007","journal-title":"Molecular and cellular biochemistry"},{"issue":"10","key":"ref34","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.clinbiochem.2004.06.002","article-title":"The natriuretic peptides and their role in disorders of right heart dysfunction and pulmonary hypertension","volume":"37","author":"LB Yap","year":"2004","journal-title":"Clinical biochemistry"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1161\/01.HYP.28.1.22","article-title":"Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension","volume":"28","author":"T Nishikimi","year":"1996","journal-title":"Hypertension"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.yjmcc.2006.05.006","article-title":"Global changes in gene expression during cardiac hypertrophy: a new direction of cardiac signaling research","volume":"41","author":"S Usui","year":"2006","journal-title":"Journal of molecular and cellular cardiology"},{"issue":"1\u20132","key":"ref37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2011.04.010","article-title":"AMPK activation enhances PPARalpha activity to inhibit cardiac hypertrophy via ERK1\/2 MAPK signaling pathway","volume":"511","author":"R Meng","year":"2011","journal-title":"Archives of biochemistry and biophysics"},{"issue":"8","key":"ref38","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrm1983","article-title":"Regulation of cardiac hypertrophy by intracellular signalling pathways","volume":"7","author":"J Heineke","year":"2006","journal-title":"Nature reviews Molecular cell biology"},{"key":"ref39","first-page":"6","article-title":"Cardiovascular hypertrophy and hypertension: causes and consequences","volume":"2","author":"PI Korner","year":"1995","journal-title":"Blood pressure Supplement"},{"issue":"1","key":"ref40","first-page":"87","article-title":"Relation of renin-angiotensin system activity to left ventricular hypertrophy and function in experimental and human hypertension","volume":"3","author":"RB Devereux","year":"1987","journal-title":"Journal of clinical hypertension"},{"issue":"4","key":"ref41","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1194\/jlr.M012757","article-title":"Small-molecule inhibitors of FABP4\/5 ameliorate dyslipidemia but not insulin resistance in mice with diet-induced obesity","volume":"52","author":"H Lan","year":"2011","journal-title":"Journal of lipid research"},{"issue":"17","key":"ref42","doi-asserted-by":"crossref","first-page":"7686","DOI":"10.1073\/pnas.92.17.7686","article-title":"A synthetic inhibitor of the mitogen-activated protein kinase cascade","volume":"92","author":"DT Dudley","year":"1995","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"23","key":"ref43","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1212\/WNL.0b013e31821e54b3","article-title":"Serum adipocyte fatty acid-binding protein associated with ischemic stroke and early death","volume":"76","author":"AW Tso","year":"2011","journal-title":"Neurology"},{"issue":"12","key":"ref44","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1161\/CIRCULATIONAHA.106.647503","article-title":"Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study","volume":"115","author":"A Xu","year":"2007","journal-title":"Circulation"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2337\/dc08-1333","article-title":"Circulating levels of adipocyte and epidermal fatty acid-binding proteins in relation to nephropathy staging and macrovascular complications in type 2 diabetic patients","volume":"32","author":"DC Yeung","year":"2009","journal-title":"Diabetes care"},{"issue":"7","key":"ref46","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1042\/CS20150073","article-title":"Deficiency of adipocyte fatty-acid-binding protein alleviates myocardial ischaemia\/reperfusion injury and diabetes-induced cardiac dysfunction","volume":"129","author":"M Zhou","year":"2015","journal-title":"Clinical science"},{"issue":"24","key":"ref47","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa072761","article-title":"Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes","volume":"356","author":"SE Nissen","year":"2007","journal-title":"The New England journal of medicine"},{"issue":"24","key":"ref48","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1001\/jama.2013.284788","article-title":"FDA eases restrictions on the glucose-lowering drug rosiglitazone","volume":"310","author":"M Mitka","year":"2013","journal-title":"Jama"},{"issue":"35","key":"ref49","doi-asserted-by":"crossref","first-page":"14074","DOI":"10.1073\/pnas.0610906104","article-title":"Genetic inhibition of cardiac ERK1\/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo","volume":"104","author":"NH Purcell","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"23","key":"ref50","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1093\/emboj\/19.23.6341","article-title":"The MEK1-ERK1\/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice","volume":"19","author":"OF Bueno","year":"2000","journal-title":"The EMBO journal"},{"issue":"9","key":"ref51","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/ijo.2013.241","article-title":"Calcium-dependent release of adipocyte fatty acid binding protein from human adipocytes","volume":"38","author":"I Schlottmann","year":"2014","journal-title":"International journal of obesity"},{"issue":"6","key":"ref52","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/MCB.01122-14","article-title":"Uncoupling lipid metabolism from inflammation through fatty acid binding protein-dependent expression of UCP2","volume":"35","author":"H Xu","year":"2015","journal-title":"Molecular and cellular biology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0157372","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T17:17:52Z","timestamp":1656695872000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0157372"}},"subtitle":[],"editor":[{"given":"Xianwu","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,6,13]]},"references-count":52,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,6,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0157372","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,13]]}}}